On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and with his cancer patients, shared their challenging experiences during this pandemic.
Go to article Click Here
Go to article Click Here
Reference: Jew S, et al. Target Oncol. 2023;doi:10.1007/s11523-023-00990-6 - James R. Berenson, MD Berenson Cancer...
Blood Journal: A Phase 1 Trial: Evaluating…Methylprednisolone: RE: ASH 2023 San Diego, CA December 9-11 Media...
Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests...